We demonstrated that TGF‐β treatment induced a significant increase in EGFR expression in breast cancer cells, and EGFR was essential for TGF‐β‐induced enhancement of the migration and invasion abilities of breast cancer cells. Here, TGFB1 is linked to breast carcinoma.